|Bid||35.00 x 1300|
|Ask||35.50 x 1000|
|Day's Range||34.40 - 35.65|
|52 Week Range||14.52 - 44.66|
|Beta (5Y Monthly)||1.63|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 06, 2020|
|1y Target Est||N/A|
Cheesecake Factory (CAKE) is likely to benefit from menu innovation and technological upgrades. However, high operating costs and low traffic due to the coronavirus outbreak are concerns.
Shares of well-known restaurant chains The Cheesecake Factory (NASDAQ: CAKE), Dave & Buster's Entertainment (NASDAQ: PLAY), and BJ's Restaurants (NASDAQ: BJRI) are soaring 23%, 34%, and 26% higher, respectively, after highly promising data on a leading COVID-19 vaccine hit the news feeds. Shares of Pfizer (NYSE: PFE) also jumped more than 10% higher after releasing information that its clinical trial showed its leading vaccine candidate was more than 90% effective in preventing COVID-19 in participants who had no evidence of prior infection. The news was a breath of fresh air for brick-and-mortar businesses that have been clobbered by social distancing and more cautious consumer behavior amid the pandemic.
Cheesecake Factory (NASDAQ: CAKE) shares are trading higher after Deutsche Bank upgraded the stock from Hold to Buy and announced a $40 price target.Cheesecake Factory owns and operates restaurants in the United States and Canada under brands that include Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties.The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and others. Most of the company's revenue comes from The Cheesecake Factory restaurants segment.Cheesecake Factory shares were trading up 22.02% at $37.90 on Monday. The stock has a 52-week high of $44.66 and a 52-week low of $14.52.Latest Ratings for CAKE DateFirmActionFromTo Nov 2020Deutsche BankUpgradesHoldBuy Nov 2020Credit SuisseMaintainsNeutral Nov 2020Morgan StanleyMaintainsUnderweight View More Analyst Ratings for CAKE View the Latest Analyst RatingsSee more from Benzinga * Click here for options trades from Benzinga * Why WR Grace's Stock Is Trading Higher Today * Why HighPoint Resources Stock Is Trading Lower Today(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.